Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.473ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.473ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.473NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.595.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.595.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.76.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.76.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.76.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.76.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.38.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.38.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.109ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.109ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.109ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.109NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.361ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.361ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.361ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.361NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.417ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.417ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.417ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.417NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AM.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used